Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma by Ben F.J. Goudsmit, Ilaria Prosepe, Maarten E. Tushuizen, Vincenzo Mazzaferro, Ian P.J. Alwayn, Bart van Hoek, Andries E. Braat, Hein Putter

Get full text

Acute Liver Injury and Acute Liver Failure following Bariatric Surgery by Rowan F. van Golen, Nadine E. de Waard, Laura R. Moolenaar, Akin Inderson, Stijn Crobach, Alexandra M.J. Langers, Bart van Hoek, Maarten E. Tushuizen

Get full text

Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis by Sofia Karkampouna, Danny van der Helm, Mario Scarpa, Bart van Hoek, Hein W. Verspaget, Marie-Jose Goumans, Minneke J. Coenraad, Boudewijn P.T. Kruithof, Marianna Kruithof-de Julio

Get full text

Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt by Maria Chiara Meucci, Merte M. Hoogerduijn Strating, Steele C. Butcher, Catharina S. P. vanRijswijk, Bart Van Hoek, Victoria Delgado, Jeroen J. Bax, Maarten E. Tushuizen, Nina Ajmone Marsan

Get full text

Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response... by Michelle D. van den Beukel, Anna E. C. Stoelinga, Adriaan J. van der Meer, Stef van der Meulen, Lu Zhang, Maarten E. Tushuizen, Bart van Hoek, Leendert A. Trouw

Get full text

Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment by Michelle D. van den Beukel, Anna E. C. Stoelinga, Adriaan J. van der Meer, Stef van der Meulen, Lu Zhang, Maarten E. Tushuizen, Bart van Hoek, Leendert A. Trouw

Get full text

B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis by Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, Camiel M.J. Marijnissen, Rob A. de Man, Annemiek A. van der Eijk, Adriaan J. van der Meer, Leendert A. Trouw, Bart van Hoek

Get full text

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis. by Annarein J C Kerbert, Len Verbeke, Fang W T Chiang, Wim Laleman, Johan J van der Reijden, Wim van Duijn, Frederik Nevens, Ron Wolterbeek, Bart van Hoek, Hein W Verspaget, Minneke J Coenraad

Get full text

Predictive Capacity of Risk Models in Liver Transplantation by Jacob D. de Boer, MD, Hein Putter, PhD, Joris J. Blok, MD, PhD, Ian P.J. Alwayn, MD, PhD, Bart van Hoek, MD, PhD, Andries E. Braat, MD, PhD

Get full text

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival by Annarein J. C. Kerbert, Hein W. Verspaget, Àlex Amorós Navarro, Rajiv Jalan, Elsa Solà, Daniel Benten, François Durand, Pere Ginès, Johan J. van der Reijden, Bart van Hoek, Minneke J. Coenraad, for the CANONIC Study Investigators of the EASL-CLIF Consortium

Get full text

Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation. by Marcel Janse, Bert-Jan F de Rooij, Bart van Hoek, Arie P van den Berg, Robert J Porte, Hans Blokzijl, Minneke J Coenraad, Bouke G Hepkema, Alexander F Schaapherder, Jan Ringers, Rinse K Weersma, Hein W Verspaget

Get full text

Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study by Thijmen Visseren, Nicole S. Erler, Julie K. Heimbach, John E. Eaton, Nazia Selzner, Aliya Gulamhusein, Frans van der Heide, Robert J. Porte, Bart van Hoek, Ian P.J. Alwayn, Herold J. Metselaar, Jan N.M. IJzermans, Sarwa Darwish Murad

Get full text

Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses by Jan C. Kamp, Naomi N. Kappe, Carlos Fernández Moro, Jan Fuge, Mark P. Kuehnel, Sabine Wrenger, Tobias Welte, Bart van Hoek, Danny D. Jonigk, Padmini P. S. J. Khedoe, Pavel Strnad, Mikael Björnstedt, Jan Stolk, Sabina Janciauskiene, Antal Nemeth

Get full text

The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030 by Marleen van Dijk, Sylvia M. Brakenhoff, Cas J. Isfordink, Wei-Han Cheng, Hans Blokzijl, Greet Boland, Anthonius S. M. Dofferhoff, Bart van Hoek, Cees van Nieuwkoop, Milan J. Sonneveld, Marc van der Valk, Joost P. H. Drenth, Robert J. de Knegt

Get full text

Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study. by Floor A C Berden, Robert J de Knegt, Hans Blokzijl, Sjoerd D Kuiken, Karel J L van Erpecum, Sophie B Willemse, Jan den Hollander, Marit G A van Vonderen, Pieter Friederich, Bart van Hoek, Carin M J van Nieuwkerk, Joost P H Drenth, Wietske Kievit

Get full text

Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preve... by Rianne van Rijn, Aad P. van den Berg, Joris I. Erdmann, Nigel Heaton, Bart van Hoek, Jeroen de Jonge, Henri G. D. Leuvenink, Shekar V. K. Mahesh, Sarah Mertens, Diethard Monbaliu, Paolo Muiesan, M. Thamara P. R. Perera, Wojciech G. Polak, Xavier Rogiers, Roberto I. Troisi, Yvonne de Vries, Robert J. Porte

Get full text

Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time by Joris J. Blok, MD, Hein Putter, PhD, Herold J. Metselaar, MD, PhD, Robert J. Porte, MD, PhD, Federica Gonella, MD, PhD, Jeroen de Jonge, MD, PhD, Aad P. van den Berg, MD, PhD, Josephine van der Zande, MSc, Jacob D. de Boer, MD, Bart van Hoek, MD, PhD, Andries E. Braat, MD, PhD

Get full text

Modifying Tacrolimus-related Toxicity After Liver Transplantation Comparing Life Cycle Pharma Tacrolimus Versus Extended-released Tacrolimus: A Multicenter, Randomized Controlled T... by Midas B. Mulder, PharmD, Bart van Hoek, MD, PhD, Wojtek G. Polak, MD, PhD, Ian P.J. Alwayn, MD, PhD, Brenda C.M. de Winter, PharmD, PhD, Sarwa Darwish Murad, MD, PhD, Elke Verhey-Hart, BSc, Lara Elshove, MSc, Nicole S. Erler, Dipl-Stat, PhD, Dennis A. Hesselink, MD, PhD, Caroline M. den Hoed, MD, PhD, Herold J. Metselaar, MD, PhD

Get full text

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multi... by Anna E. C. Stoelinga, Maarten E. Tushuizen, Wilbert B. van den Hout, Mar D. M. Rodriguez Girondo, Elsemieke S. de Vries, Amar D. Levens, Dirk-Jan A. R. Moes, Tom J. G. Gevers, Suzanne van der Meer, Hans T. Brouwer, Hendrik J. M. de Jonge, Ynte S. de Boer, Ulrich H. W. Beuers, Adriaan J. van der Meer, Aad P. van den Berg, Maureen M. J. Guichelaar, Joost P. H. Drenth, Bart van Hoek, on behalf of the Dutch Autoimmune Hepatitis Group

Get full text

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled tria... by Romée J. A. L. M. Snijders, Anna E. C. Stoelinga, Tom J. G. Gevers, Simon Pape, Maaike Biewenga, Robert C. Verdonk, Hendrik J. M. de Jonge, Jan Maarten Vrolijk, Sjoerd F. Bakker, Thomas Vanwolleghem, Ynto S. de Boer, Martine A. M. C. Baven Pronk, Ulrich H. W. Beuers, Adriaan J. van der Meer, Nicole M. F. van Gerven, Marijn G. M. Sijtsma, Bart J. Verwer, Ingrid A. M. Gisbertz, Maartje Bartelink, Floris F. van den Brand, Kerem Sebib Korkmaz, Aad P. van den Berg, Maureen M. J. Guichelaar, Khalida Soufidi, Amar D. Levens, Bart van Hoek, Joost P. H. Drenth, on behalf of the Dutch Autoimmune Hepatitis Working Group

Get full text